[1] 杨玉, 周欢娣, 薛晓英, 等.NRAGE影响人食管癌细胞放射抗性的作用及其机制研究[J].中国癌症杂志, 2020, 30(1):47-54.
[2] LANG X, GREEN M D, WANG W, et al.Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11[J].Cancer Discov, 2019, 9(12):1673-1685.
[3] MOHANTY R, CHOWDHURY C R, AREGA S, et al.CAR T cell therapy:a new era for cancer treatment(review)[J].Oncol Rep, 2019, 42(6):2183-2195.
[4] WAGNER J, WICKMAN E, DERENZO C, et al.CAR T cell therapy for solid tumors:bright for dark reality?[J].Mol Ther, 2020, 28(11):2320-2339.
[5] GRUSZKA A M, VALLI D, ALCALAY M.Wnt signalling in acute myeloid leukaemia[J].Cells, 2019, 8(11):1403.
[6] KATO K, SHAH M A, ENZINGER P, et al.Phase Ⅲ study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer[J].Future Oncol, 2019, 15(10):1057-1066.
[7] 钱龙, 富智, 丁辉, 等.食管癌组织中前梯度蛋白2和上皮性钙黏蛋白的表达及其临床意义[J].现代医学, 2019, 47(4):406-411.
[8] SHIN W S, LEE H W, LEE S T.Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF[J].FASEB J, 2019, 33(11):12960-12971.
[9] JIE Y, LIU G, FENG L, et al.PTK7-targeting CAR T-Cells for the treatment of lung cancer and other malignancies[J].Front Immunol, 2021, 12(1):221-230.
[10] HONG M, CLUBB J D, CHEN Y Y.Engineering CAR-T cells for next-generation cancer therapy[J].Cancer Cell, 2020, 38(4):473-488.
[11] FEINS S, KONG W, WILLIAMS E F, et al.An introduction to chimeric antigen receptor(CAR) T-cell immunotherapy for human cancer[J].Am J Hematol, 2019, 94(S1):S3-S9.
[12] 王自闯, 陈小永, 张娟.枸杞多糖联合顺铂对肝癌小鼠抑瘤作用及其对免疫功能的影响[J].东南大学学报(医学版), 2018, 37(5):896-900.
[13] YAMASHITA M, PASSEGUÉ E.TNF-α coordinates hematopoietic stem cell survival and myeloid regeneration[J].Cell Stem Cell, 2019, 25(3):357-372.
[14] TURNER C T, HIROYASU S, GRANVILLE D J.Granzyme B as a therapeutic target for wound healing[J].Expert Opin Ther Targets, 2019, 23(9):745-754.
[15] KANG S, TANAKA T, NARAZAKI M, et al.Targeting interleukin-6 signaling in clinic[J].Immunity, 2019, 50(4):1007-1023.
[16] WANG X, WONG K, OUYANG W, et al.Targeting IL-10 family cytokines for the treatment of human diseases[J].Cold Spring Harb Perspect Biol, 2019, 11(2):2854.
[17] MOROKAWA H, YAGYU S, HASEGAWA A, et al.Autologous non-human primate model for safety assessment of piggyBac transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptor[J]. Clin Transl Immunology, 2020, 9(11):e1207. |